Scinai Immunotherapeutics reports 1H results
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
More in Finance & Markets
Asana Reaches Analyst Target Price
In recent trading, shares of Asana Inc (Symbol: ASAN) have crossed above the average analyst 12-month target price of $9.56, changing hands for $9.58/share.
Greenwallet solves the naira card problem costing nigerians every time they shop online
There is a specific frustration reserved for the moment a Nigerian tries to pay for something online and watches the transaction fail.
New Zealand Dollar: Retail slump yet hikes priced – BBH
Brown Brothers Harriman’s (BBH) Elias Haddad highlights that New Zealand retail sales volumes unexpectedly fell in Q2, driven by fuel and motor-related categories, while core sales still rose, showing…
TransMedics Group Reaches Analyst Target Price
In recent trading, shares of TransMedics Group Inc (Symbol: TMDX) have crossed above the average analyst 12-month target price of $94.36, changing hands for $94.77/share.
AVTR Crosses Above Average Analyst Target
In recent trading, shares of Avantor Inc (Symbol: AVTR) have crossed above the average analyst 12-month target price of $14.39, changing hands for $14.46/share.
Gold extends rally as markets await US PCE and Warsh’s Jackson Hole speech
Gold (XAU/USD) extends its advance on Monday, building on the strong rally seen last week following the US Treasury’s buyback announcement.